JNCE - Jounce Therapeutics GAAP EPS of -$0.65 beats by $0.04 August, 04 2022 07:05 AM Jounce Therapeutics Inc. Jounce Therapeutics press release ( NASDAQ: JNCE ): Q2 GAAP EPS of -$0.65 beats by $0.04 . Cash, cash equivalents and investment of $162.25M For further details see: Jounce Therapeutics GAAP EPS of -$0.65 beats by $0.04